News from vanda pharmaceuticals inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 07, 2014, 07:00 ET

Vanda Pharmaceuticals Reports Second Quarter 2014 Results

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the...

Jul 17, 2014, 19:00 ET

Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Jun 03, 2014, 07:00 ET

European Medicines Agency Accepts HETLIOZ™ (tasimelteon) Marketing Authorization Application for Non-24-Hour Sleep-Wake Disorder in the Totally Blind

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that its Marketing Authorization Application (MAA) for oral...

Jun 02, 2014, 19:00 ET

HETLIOZ™ (tasimelteon) Data in Patients with Non-24-Hour Sleep-Wake Disorder to be presented at SLEEP 2014 meeting

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) will present additional data from its HETLIOZ™ (tasimelteon) clinical development...

May 29, 2014, 21:00 ET

Vanda Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the...

May 08, 2014, 07:00 ET

Vanda Pharmaceuticals Reports First Quarter 2014 Results

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the...

Apr 24, 2014, 17:30 ET

Vanda Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 8, 2014

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Apr 09, 2014, 19:00 ET

Vanda Pharmaceuticals Announces Availability of HETLIOZ™ (tasimelteon) for Non-24-Hour Sleep-Wake Disorder (Non-24)

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced the availability of HETLIOZ™.  HETLIOZ™ is the first...

Feb 28, 2014, 07:00 ET

Blind Adventurer, Erik Weihenmayer, Launches National Campaign to Raise Awareness of Non-24-Hour Sleep-Wake Disorder

 Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that it has partnered with Erik Weihenmayer, a world-renowned adventurer and...

Feb 13, 2014, 07:00 ET

Vanda Pharmaceuticals Reports Fourth Quarter 2013 and Full Year 2013 Results

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Jan 31, 2014, 13:45 ET

FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder

 Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Jan 23, 2014, 17:00 ET

Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Dec 03, 2013, 17:00 ET

Vanda Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Nov 14, 2013, 22:55 ET

FDA Advisory Committee Recommends Approval of HETLIOZ™ for the Treatment of Non-24-Hour-Disorder (Non-24) in the Totally Blind

 Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) announced today that the U.S. Food and Drug Administration's (FDA) Peripheral and Central...

Nov 14, 2013, 07:05 ET

Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ™ NDA

 Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Nov 07, 2013, 06:55 ET

Vanda Pharmaceuticals Reports Third Quarter 2013 Results

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Oct 21, 2013, 19:00 ET

Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Oct 16, 2013, 16:01 ET

Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013

Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the...

Sep 10, 2013, 17:00 ET

Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2013 Healthcare Conference

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products...

Aug 07, 2013, 08:47 ET

Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced the sale of 4,680,000 shares of its common stock in an underwritten public...